Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices 11947 

Unmitigable Adverse Impact Analysis 

and Determination 

There are no relevant subsistence uses 

of the affected marine mammal stocks or 

species implicated by this action. 

Therefore, NMFS has determined that 

the total taking of affected species or 

stocks would not have an unmitigable 

adverse impact on the availability of 

such species or stocks for taking for 

subsistence purposes. 

Endangered Species Act 

Section 7(a)(2) of the Endangered 

Species Act of 1973 (16 U.S.C. 1531 et 

seq.) requires that each Federal agency 

insure that any action it authorizes, 

funds, or carries out is not likely to 

jeopardize the continued existence of 

any endangered or threatened species or 

result in the destruction or adverse 

modification of designated critical 

habitat. To ensure ESA compliance for 

the issuance of IHAs, NMFS consults 

internally, in this case with the NMFS 

Greater Atlantic Regional Fisheries 

Office (GARFO), whenever NMFS 

proposes to authorize take for 

endangered or threatened species. 

The NMFS Office of Protected 

Resources is proposing to authorize the 

incidental take of four species of marine 

mammals listed under the ESA: the 

North Atlantic right, fin, sei, and sperm 

whale. The OPR has requested initiation 

of section 7 consultation with NMFS 

GARFO for the issuance of this IHA. 

NMFS will conclude the ESA section 7 

consultation prior to reaching a 

determination regarding the proposed 

issuance of the authorization. 

Proposed Authorization 

As a result of these preliminary 

determinations, NMFS proposes to issue 

an IHA to Mayflower for conducting 

marine site characterization surveys 

offshore of Massachusetts in the area of 

the Commercial Lease of Submerged 

Lands for Renewable Energy 

Development on the Outer Continental 

Shelf (OCS–A 0521) and along a 

potential submarine cable route to 

landfall at Falmouth, Massachusetts for 

a period of one year from the date of 

issuance, provided the previously 

mentioned mitigation, monitoring, and 

reporting requirements are incorporated. 

A draft of the proposed IHA can be 

found at https://

www.fisheries.noaa.gov/permit/ 

incidental-take-authorizations-undermarine-mammal-protection-act. 

Request for Public Comments 

NMFS requests comment on our 

analyses, the proposed authorization, 

and any other aspect of this notice of 

proposed IHA for the proposed marine 

site characterization surveys. NMFS also 

requests at this time comment on the 

potential Renewal of this proposed IHA 

as described in the paragraph below. 

Please include with your comments any 

supporting data or literature citations to 

help inform decisions on the request for 

this IHA or a subsequent Renewal IHA. 

On a case-by-case basis, NMFS may 

issue a one-time, one-year Renewal IHA 

following notice to the public providing 

an additional 15 days for public 

comments when (1) up to another year 

of identical or nearly identical, or nearly 

identical, activities as described in the 

Description of Proposed Activities 

section of this notice is planned or (2) 

the activities as described in the 

Description of Proposed Activities 

section of this notice would not be 

completed by the time the IHA expires 

and a Renewal would allow for 

completion of the activities beyond that 

described in the Dates and Duration 

section of this notice, provided all of the 

following conditions are met: 

• A request for renewal is received no 

later than 60 days prior to the needed 

Renewal IHA effective date (recognizing 

that the Renewal IHA expiration date 

cannot extend beyond one year from 

expiration of the initial IHA); 

• The request for renewal must 

include the following: 

1. An explanation that the activities to 

be conducted under the requested 

Renewal IHA are identical to the 

activities analyzed under the initial 

IHA, are a subset of the activities, or 

include changes so minor (e.g., 

reduction in pile size) that the changes 

do not affect the previous analyses, 

mitigation and monitoring 

requirements, or take estimates (with 

the exception of reducing the type or 

amount of take); and 

2. A preliminary monitoring report 

showing the results of the required 

monitoring to date and an explanation 

showing that the monitoring results do 

not indicate impacts of a scale or nature 

not previously analyzed or authorized. 

Upon review of the request for 

Renewal, the status of the affected 

species or stocks, and any other 

pertinent information, NMFS 

determines that there are no more than 

minor changes in the activities, the 

mitigation and monitoring measures 

will remain the same and appropriate, 

and the findings in the initial IHA 

remain valid. 

Dated: February 24, 2021. 

Donna S. Wieting, 

Director, Office of Protected Resources, 

National Marine Fisheries Service. 

[FR Doc. 2021–04161 Filed 2–26–21; 8:45 am] 

BILLING CODE 3510–22–P 

DEPARTMENT OF COMMERCE 

Patent and Trademark Office 

[Docket No.: PTO–P–2021–0011] 

Grant of Interim Extension of the Term 

of U.S. Patent No. 6,953,476; Reducer®

AGENCY: United States Patent and 

Trademark Office, Department of 

Commerce. 

ACTION: Notice of interim patent term 

extension. 

SUMMARY: The United States Patent and 

Trademark Office has issued an order 

granting a one-year interim extension of 

the term of U.S. Patent No. 6,953,476. 

FOR FURTHER INFORMATION CONTACT: Ali 

Salimi by telephone at 571–272–0909; 

by mail marked to his attention and 

addressed to the Commissioner for 

Patents, Mail Stop Hatch-Waxman PTE, 

P.O. Box 1450, Alexandria, VA 22313– 

1450; by fax marked to his attention at 

571–273–0909; or by email to 

ali.salimi@uspto.gov. 

SUPPLEMENTARY INFORMATION: Section 

156 of Title 35, United States Code, 

generally provides that the term of a 

patent may be extended for a period of 

up to five years if the patent claims a 

product, or a method of making or using 

a product, that has been subject to 

certain defined regulatory review, and 

that the patent may be extended for 

interim periods of up to one year if the 

regulatory review is anticipated to 

extend beyond the expiration date of the 

patent. 

On February 19, 2021, Neovasc 

Medical Ltd., the patent owner of 

record, timely filed an application 

under 35 U.S.C. 156(d)(5) for a second 

interim extension of the term of U.S. 

Patent No. 6,953,476. The patent claims 

a catheter delivered implantable device, 

Reducer®. The application for patent 

term extension indicates that a 

Premarket Approval Application (PMA) 

P190035 was submitted to the Food and 

Drug Administration (FDA) on 

December 31, 2019. 

Review of the patent term extension 

application indicates that, except for 

permission to market or use the product 

commercially, the subject patent would 

be eligible for an extension of the patent 

term under 35 U.S.C. 156, and that the 

patent should be extended for one year 

as required by 35 U.S.C. 156(d)(5)(B). 

Because the regulatory review period 

will continue beyond the extended 

expiration date of the patent, March 27, 

2021, interim extension of the patent 

term under 35 U.S.C. 156(d)(5) is 

appropriate. 

An interim extension under 35 U.S.C. 

156(d)(5) of the term of U.S. Patent No. 

11948 Federal Register / Vol. 86, No. 38 / Monday, March 1, 2021 / Notices 

6,953,476 is granted for a period of one 

year from the extended expiration date 

of the patent. 

Robert Bahr, 

Deputy Commissioner for Patents, United 

States Patent and Trademark Office. 

[FR Doc. 2021–04168 Filed 2–26–21; 8:45 am] 

BILLING CODE 3510–16–P 

DEPARTMENT OF DEFENSE 

[Transmittal No. 20–48] 

Arms Sales Notification 

AGENCY: Defense Security Cooperation 

Agency, Department of Defense (DoD). 

ACTION: Arms sales notice. 

SUMMARY: The Department of Defense is 

publishing the unclassified text of an 

arms sales notification. 

FOR FURTHER INFORMATION CONTACT: 

Karma Job at karma.d.job.civ@mail.mil 

or (703) 697–8976. 

SUPPLEMENTARY INFORMATION: This 

36(b)(1) arms sales notification is 

published to fulfill the requirements of 

section 155 of Public Law 104–164 

dated July 21, 1996. The following is a 

copy of a letter to the Speaker of the 

House of Representatives, Transmittal 

20–48 with attached Policy Justification 

and Sensitivity of Technology. 

Dated: February 23, 2021. 

Aaron T. Siegel, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

BILLING CODE 5001–06–P